Vivos Therapeutics, Inc. Operating Lease, Liability, Current
Vivos Therapeutics, Inc. (VVOS) had Operating Lease, Liability, Current of $790.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Current $790.00K.
- 2026-03-31: Operating Lease, Liability, Current $744.00K.
- 2025-12-31: Operating Lease, Liability, Current $672.00K.
- 2025-09-30: Operating Lease, Liability, Current $734.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $790.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $744.00K 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $672.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $734.00K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $654.00K 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $467.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $477.00K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $485.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $484.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $483.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $474.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $460.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $447.00K 10-Q · filed 2023-08-16 | |
| 2023-03-31 | $433.00K 10-Q · filed 2023-06-08 | |
| 2022-12-31 | $419.00K 10-K/A · filed 2024-07-30 | |
| 2022-09-30 | $446.00K 10-Q · filed 2022-12-20 | |
| 2022-06-30 | $383.00K 10-Q · filed 2022-12-20 | |
| 2022-03-31 | $357.00K 10-Q/A · filed 2022-11-25 | |
| 2021-12-31 | $72.00K 10-Q · filed 2022-12-20 | $69.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |